Basic Information
Vyant Bio's drug discovery platform maximizes the likelihood of clinical success. By integrating human-based microOrgan® technology, state-of-the-art engineering, advanced data science, rigorous regulation, and a profound personal commitment to the field, we accelerate the process and mitigate risks—identifying the most viable, safe, and effective candidate drugs with greater predictive value that can transform lives. Vyant Bio’s dynamic drug discovery engine is powered by the convergence of innovative bioengineering technology, industry-leading data science, and world-class IND-enabling development strategies—all seamlessly coordinated within a reliable resource. Our robust AnalytiX™ platform, positioned at the intersection of human biology and machine learning, is unparalleled in its ability to rapidly and comprehensively analyze powerful functional data to identify the most promising drug candidates, targets, and biomarkers through a quantitative, unbiased ranking approach.
Vyant Bio, Inc.
NewJersey,United States of America
51~100 people
January 01, 1999
Info@VyantBio.com

